Management of dependent use of illicit opioids

BMJ. 2020 Mar 9:368:m710. doi: 10.1136/bmj.m710.

Authors

Caroline Mitchell¹, Neil Dolan², Kenneth M Dürsteler^{3

4}

Affiliations

¹ Academic Unit of Primary Medical Care, Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK c.mitchell@sheffield.ac.uk.
² University of Sheffield, Sheffield, UK.
³ Center for Addictive Disorders, University of Basel Psychiatric Hospital, Basel, Switzerland.
⁴ University Hospital of Psychiatry Zurich, Department for Psychiatry, Psychotherapy and Psychosomatics, Centre for Addictive Disorders, Zurich, Switzerland.

PMID: 32152035
DOI: 10.1136/bmj.m710

No abstract available

Publication types

Review

MeSH terms

Behavior Therapy
Drug Overdose / drug therapy
Harm Reduction
Humans
Illicit Drugs*
Medical History Taking
Naloxone / therapeutic use
Narcotic Antagonists / therapeutic use
Narcotics / agonists
Opioid-Related Disorders / diagnosis
Opioid-Related Disorders / psychology
Opioid-Related Disorders / therapy*
Patient Care Planning
Social Support

Substances

Illicit Drugs
Narcotic Antagonists
Narcotics
Naloxone